| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BIOTIME INC | 20,084 | 24,000 | 0.00% | ||
| 2 | CYCLACEL PHARMACEUTICALS INC | 13,253 | 52,000 | 0.00% | ||
| 3 | APTOSE BIOSCIENCES INC | 33,397 | 84,000 | 0.00% | ||
| 4 | LA JOLLA PHARMACEUTICAL CO | 13,746 | 371,000 | 0.00% | ||
| 5 | CHEMOCENTRYX INC | 49,064 | 397,000 | 0.00% | ||
| 6 | Foundation Medicine | 20,892 | 440,000 | 0.00% | ||
| 7 | UNIQURE NV | 30,000 | 496,000 | 0.00% | ||
| 8 | ACHAOGEN INC COM | 100,000 | 574,000 | 0.00% | ||
| 9 | RITTER PHARMACEUTICALS INC | 400,000 | 680,000 | 0.01% | ||
| 10 | DISCOVERY LABORATORIES INC N | 3,569,643 | 764,000 | 0.01% | ||
| 11 | FIVE PRIME THERAPEUTICS INC | 19,247 | 799,000 | 0.01% | ||
| 12 | ARBUTUS BIOPHARMA CORP | 180,582 | 804,000 | 0.01% | ||
| 13 | Aldeyra Therapeutics Inc | 142,000 | 963,000 | 0.01% | ||
| 14 | BIODELIVERY SCIENCES INTL IN | 210,021 | 1,006,000 | 0.01% | ||
| 15 | CHIMERIX INC | 115,216 | 1,031,000 | 0.01% | ||
| 16 | ALNYLAM PHARMACEUTICALS INC | 11,340 | 1,068,000 | 0.01% | ||
| 17 | ADAPTIMMUNE THERAPEUTICS PLC | 100,000 | 1,206,000 | 0.01% | ||
| 18 | PALATIN TECHNOLOGIES INC COM | 2,050,000 | 1,361,000 | 0.01% | ||
| 19 | TENAX THERAPEUTICS INC | 420,000 | 1,378,000 | 0.01% | ||
| 20 | ACCELERON PHARMA INC | 28,765 | 1,403,000 | 0.01% | ||
| 21 | Marinus Pharmaceuticals Inc | 200,000 | 1,528,000 | 0.01% | ||
| 22 | CELLECTIS S A | 50,000 | 1,552,000 | 0.01% | ||
| 23 | CYTRX CORP | 659,995 | 1,749,000 | 0.01% | ||
| 24 | AURINIA PHARMACEUTICALS INC | 711,499 | 1,789,000 | 0.01% | ||
| 25 | DYNAVAX TECHNOLOGIES CORP | 75,000 | 1,812,000 | 0.02% | ||
| 26 | ASSEMBLY BIOSCIENCES INC | 250,000 | 1,878,000 | 0.02% | ||
| 27 | MEDIWOUND ORD | 225,000 | 1,922,000 | 0.02% | ||
| 28 | IRONWOOD PHARMACEUTICALS INC | 169,163 | 1,961,000 | 0.02% | ||
| 29 | MAST THERAPEUTICS INC COM | 4,797,442 | 2,016,000 | 0.02% | ||
| 30 | STEMLINE THERAPEUTICS INC | 333,497 | 2,104,000 | 0.02% | ||
| 31 | OHR PHARMACEUTICAL INC | 370,370 | 2,274,000 | 0.02% | ||
| 32 | PROTALIX BIOTHERAPEUTICS INC | 3,423,000 | 2,375,000 | 0.02% | PRN | |
| 33 | ENANTA PHARMACEUTICALS INC | 75,357 | 2,488,000 | 0.02% | ||
| 34 | TRILLIUM THERAPEUTICS INC | 211,792 | 2,671,000 | 0.02% | ||
| 35 | Natera, Inc. | 250,000 | 2,700,000 | 0.02% | ||
| 36 | OPHTHOTECH CORP | 35,649 | 2,800,000 | 0.02% | ||
| 37 | ARRAY BIOPHARMA INC 3 06/01/2020 | 3,000,000 | 2,816,000 | 0.02% | PRN | |
| 38 | FLEXION THERAPEUTICS INC | 146,642 | 2,826,000 | 0.02% | ||
| 39 | AFFIMED N V COM | 400,000 | 2,848,000 | 0.02% | ||
| 40 | KARYOPHARM THERAPEUTICS INC COM | 216,990 | 2,875,000 | 0.02% | ||
| 41 | IMMUNE DESIGN CORP | 148,937 | 2,991,000 | 0.02% | ||
| 42 | Sierra Oncology, Inc. | 200,000 | 3,008,000 | 0.02% | ||
| 43 | ADR - Nabriva Therapeutics AG- Usd | 350,000 | 3,367,000 | 0.03% | ||
| 44 | VITAE PHARMACEUTICALS INC | 187,597 | 3,396,000 | 0.03% | ||
| 45 | JUNO THERAPEUTICS INC COM | 80,000 | 3,518,000 | 0.03% | ||
| 46 | IONIS PHARMACEUTICALS INC COM | 57,140 | 3,539,000 | 0.03% | ||
| 47 | EPIZYME INC COM | 232,481 | 3,724,000 | 0.03% | ||
| 48 | LOXO ONCOLOGY INC COM | 137,735 | 3,919,000 | 0.03% | ||
| 49 | Sunesis Pharmaceuticals I | 4,450,000 | 3,994,000 | 0.03% | ||
| 50 | AMARIN CORP PLC | 2,205,710 | 4,169,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-082790, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
